Skip to content

Drug interactions

Fosaprepitant + Sunitinib

Severity: Minor

Fosaprepitant and Sunitinib: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Aprepitant formed from fosaprepitant is a moderate CYP3A4 inhibitor, but a single dose gives only a transient effect. Sunitinib exposure may rise modestly, with limited clinical consequence.

What this interaction means in plain words

Fosaprepitant and Sunitinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Fosaprepitant belongs to Gastrointestinal Tract; Sunitinib belongs to Oncology.

Evidence level: Low

Why it happens

Transient, weak-to-moderate CYP3A4 inhibition by aprepitant.

What to do

No routine adjustment is needed with single-dose use; watch for increased sunitinib adverse effects if repeated dosing is given.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Fosaprepitant and Sunitinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Fosaprepitant with Sunitinib?

MediHelp rates the interaction as minor. Fosaprepitant and Sunitinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Aprepitant formed from fosaprepitant is a moderate CYP3A4 inhibitor, but a single dose gives only a transient effect. Sunitinib exposure may rise modestly, with limited clinical consequence.

How serious is the interaction between Fosaprepitant and Sunitinib?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine adjustment is needed with single-dose use; watch for increased sunitinib adverse effects if repeated dosing is given.

What other medicines interact with Sunitinib?

MediHelp also lists interactions of Sunitinib with, for example, Adagrasib, Amiodarone, Amisulpride. The full list is on the Sunitinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in